{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001146054.2:c.90G>A",
          "cDNA Change": {
            "transcript": "NM_001146054.2",
            "ref": "G",
            "alt": "A",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_001146054.2:c.159G>A",
          "cDNA Change": {
            "transcript": "NM_001146054.2",
            "ref": "G",
            "alt": "A",
            "position": "159"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson’s disease",
    "MONDO": "MONDO:0005586"
  },
  "Experiment Method": [
    {
      "Assay Method": "Microarray analysis",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "human neuroblastoma cell lines",
        "Description": "We investigated transcriptional changes in neuroblastoma cell lines transfected with either normal or mutant (A30P or A53T) a-synuclein using microarrays"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001146054.2:c.90G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        },
        {
          "Variant": "NM_001146054.2:c.159G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Total RNA was isolated from clonal cell lines using Trizol (Invitrogen), according to manufacturer’s instructions"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "p-values were calculated using t-tests"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Quantitative RT-PCR",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "human neuroblastoma cell lines",
        "Description": "confirmation of selected genes by quantitative RT-PCR"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001146054.2:c.90G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        },
        {
          "Variant": "NM_001146054.2:c.159G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four cell lines (two each over-expressing wild-type and A53T a-synuclein), and one cell line containing pcDNA3 vector alone were hybridized to Affymetrix U95A oligonucleotide arrays"
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "human neuroblastoma cell lines",
        "Description": "We also found evidence of altered expression of dihydropteridine reductase, which indirectly regulates the synthesis of dopamine. Because of the importance of dopamine in PD, we investigated the expression of all the known genes in dopamine synthesis."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001146054.2:c.90G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        },
        {
          "Variant": "NM_001146054.2:c.159G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "anti-Nurr1 (BD Translabs, San Diego, CA, USA, 1 : 2500)"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "reprobed with b-actin (Sigma, St Louis, MO, USA; clone AC15, 1 : 5000) to verify equal loading"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}